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The Cardiac Ryanodine Receptor (RyR2): Investigating Mechanisms of
Gating at the Selectivity Filter
Jahn M. Firth, Joanne Euden, Alan J. Williams.
Institute of Molecular and Experimental Medicine, Cardiff, United Kingdom.
Ryanodine receptors (RyR) provide the pathway for release of intracellular
calcium ions (Ca2þ) that initiate muscle contraction. Mutations in cardiac
RyRs, (RyR2) underlie arrhythmia and sudden cardiac death. RyRs are therefore
an attractive therapeutic target, howevermore information regarding structure and
function is required.The enormoussizeofRyRsprecludes detailed structural anal-
ysis. Models, based on potassium channel templates, exist for the RyR pore-
forming region (PFR) providing an invaluable framework in which predictions
of specific processes of ion translocation and gating mechanisms can be tested.
Potassium channels have a conserved gating mechanism involving a distinct
hydrogen-bonding network of residues at the selectivity filter that is responsible
for holding the filter in an inactive, non-conducting conformation. This study
examines interactions of equivalent residues in RyR2 to ascertain whether a
similar gating mechanism exists.
Three alanine (D4829A, Y4813A, Y4839A) and one conserved tryptophan
(Y4839W) RyR2 mutations were constructed to assess a proposed hydrogen-
bonding network. Mutated channels formed functional homotetramers in
vivo whereby they released Ca2þ upon caffeine addition. Differences in
[3H]-ryanodine binding on isolatedWT and mutant mix membrane populations
revealed 1) altered ryanodine binding site and/or 2) altered calcium sensitivity
for mutant channels. Preliminary single-channel experiments assessing ion
handling and gating properties under steady state conditions suggest that the
selectivity filer has a role in channel gating. Conductance and open probability
(Po) for Y4839A was reduced by 15 % and 76 % respectively compared to WT
RyR2. No single-channel experiments were performed for Y4813A due to
inherent protein instability when purified. Four unique gating modes including
subconductance states for D4829A were observed. Further experiments are
required to assess the role of the selectivity filter in gating.
Study supported by the British Heart Foundation.
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Looking for the Calcium-Binding Site in the Ryanodine Receptor’s
Vestibule
Janos Almassy, Sandor Sarkozi, Istvan Jona.
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Ca2þ regulates ryanodine receptor’s (RyR) activity through a high-affinity
(activating) and a low-affinity (inhibiting) Ca2þ-binding site. Their altered
sensitivity plays an important role in the pathology of malignant hyperthermia
and heart failure. Although, the function of Ca2þ-binding sites has been exten-
sively studied, their location within the channel protein remains elusive. We
used Eu3þ as a tool to learn more about the Ca2þ-regulation of RyR, because
it has high affinity to Ca2þ-binding proteins and due to its high valency it is
more susceptible to be moved across an electric field than Ca2þ.
Eu3þwas tested on single RyR1 channels reconstituted into planar lipid bilayers.
When the activating binding site was saturated by 50 mM Ca2þ, Eu3þ potently
inhibited RyR’s open probability (kd=16755 nM nHill=250.1), but in nomi-
nally 0 [Ca2þ], low [Eu3þ] activated the channel. These results suggest that
Eu3þ acts as an agonist of both Ca2þ-binding sites. More interestingly, the action
of Eu3þwas voltage-dependent: at negativemembrane potentials, when the elec-
trical force tends to drive Eu3þ into the pore, >1 mM Eu3þ caused long closed
states by occluding the pore, but unexpectedly, %1 mM Eu3þ induced signifi-
cantly weaker inhibition compared to positive potentials (which drives positively
charged ions out from the outer vestibule). These findings led to the hypothesis
that negative potentials prevent Eu3þ-inhibition by increasing relative [Eu3þ]
in the vicinity of the activating site located within the vestibule. This idea was
further testedwith thepeptide-toxinmaurocalcine.We found thatRyRopenprob-
ability was insensitive to lowering [Ca2þ] to 100 nMas long as the toxin occluded
the vestibule. These results suggest, that maurocalcine mechanically prevented
Ca2þ from dissociating from its binding site, therefore the high-affinity binding
site (but not the low-affinity) might be located in the RyRs vestibule.
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Ligand-Dependent Conformational Changes in the Cardiac Ryanodine
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at Albany, Albany, NY, USA.Global conformational changes in the three-dimensional (3D) structure of the
calcium release channel/ryanodine receptor (RyR) occur upon ligand activa-
tion. Of several ligands that activate RyR, Ca2þ is the primary activator.
Although RyR Ca2þ activation is well characterized functionally, little is
known about the conformational changes in RyR induced by Ca2þ. Here we
generated three fluorescence resonance energy transfer (FRET)-based
conformational probes. Each of these probes was constructed by inserting a
CFP into one domain and a YFP into a neighboring domain in the
cardiac RyR (RyR2) to yield a CFP- and YFP-dual labeled RyR2 (CFP/
YFP FRET pair). These CFP/YFP FRET pairs were located in the
‘‘clamp’’ region (RyR2S2367-CFP/Y2801-YFP), the calmodulin binding region
(RyR2R3595-CFP/K4269-YFP), and the ‘‘bridge’’ region (RyR2S437-YFP/S2367-CFP),
respectively. We monitored the conformational changes in these regions by
recording the FRET signals, and the extent of Ca2þ release by measuring store
Ca2þ depletion in HEK293 cells expressing each of the CFP/YFP FRET pairs
upon activation by Ca2þ, caffeine, and ATP. Surprisingly, we found that
different ligands induced different conformational changes in different regions
of RyR2. For instance, we detected conformational changes in the clamp region
for caffeine and ATP, but not for Ca2þ, although they all induced Ca2þ release.
Considering Ca2þ as the primary activator of RyR2, we determined the impact
of cytosolic Ca2þ sensing mutation E3987A on conformational changes. Inter-
estingly, this single mutation abolishes caffeine-induced conformational
changes, but not caffeine-induced Ca2þ release. These observations demon-
strate that conformational changes in RyR2 are ligand-dependent, and
that E3987, which is critical for cytosolic Ca2þ sensing, is essential for
ligand-induced conformational changes (Supported by CFI, CIHR, HSFC,
NIH, and LCIA).
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Calcins is a novel family of scorpion peptides that bind with high affinity and
specificity to ryanodine receptors (RyRs) and increase their open probability
by inducing the appearance of a long-lasting subconductance state. Here we
report two newly-identified calcins (Vejocalcin and Urocalcin) and provide a
comprehensive analysis of the structure-function relationship of the eight
calcins known to date, based on primary sequence examination, 3D structure
modeling, and their effect on RyR1. [3H]Ryanodine binding assays, used as
index of the open probability (Po) of RyRs, revealed that all eight
calcins (Opicalcin1, Opicalcin2, Imperacalcin, Maurocalcin, Hadrucalcin,
Hemicalcin, Vejocalcin, and Urocalcin) activate RyR1 dose-dependently,
with EC50s (in nM) 0.35, 5, 8, 12, 37, 71, 91, and 523, respectively. At 1
mM, calcins significantly augmented the bell-shaped [Ca2þ]-activity curve
of RyR1 with potency Opicalcin1>Opicalcin2>Vejocalcin>Urocalcin.
In single channel recordings, the heretofore uncharacterized calcins
Opicalcin1, Opicalcin2 and Vejocalcin increased the Po of RyR1 signifi-
cantly and the fractional conductance was ~0.45, 0.30, and 0.65, respectively,
of the full conductance state. Opicalcin1, Maurocalcin, Hadrucalcin and
Vejocalcin induced Ca2þ release from rabbit skeletal SR with ED50s (in
nM) 2.850.02, 8.350.25, 1650.4, 3650.5, respectively. A clear Ca2þ
release-[3H]ryanodine binding activity correlation (r2=0.99) was obtained.
Primary sequence alignment and evolutionary analysis (ClustalW and
MEGA5.2) showed high homology among all calcins. An inhibitor
cysteine-knot (ICK) motif with babb domains stabilized by three disulfide
bridges characterizes this peptide family, although Vejocalcin lacks the b2
sheet. Positively-charged residue mutations in the high variable N-terminal
region (G1-N14) and negatively-charged residue variations in the conserved
C-terminal region (D15-R33) greatly decrease the effect of calcins on RyR1.
In conclusion, natural variation in calcin peptides offers a diversified set of
RyR ligands with capacity to modulate RyRs with high dynamic range
and potency.
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The cardiac ryanodine receptor (RyR2) is an intracellular calcium release chan-
nel composed of four ~560kDa subunits. It mediates sarcoplasmic reticulum
